Catalog Number CLR222 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bruise/Contusion (1754); Purulent Discharge (1812); Inflammation (1932); Tissue Damage (2104); Not Applicable (3189)
|
Event Date 07/01/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Product complaint # (b)(4).A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information received: what is the physicians opinion of the contributing factors to the reaction? surgeon believes to be a reaction to the adhesive.Patient pre-existing medical conditions (ie.Allergies, history of reactions).Please note patient has had prior exposure to prineo without adverse reaction for total hip replacement with the same surgeon within the prior 5 years.Patient has no known allergies and is otherwise in good health.Attempts have been made to obtain the following additional information, however not received to date: it was noted that antibiotics were prescribed and readmitted for wound management, was the reaction treated in any other manner (product removed; reoperation; reclosure; other prescription)? if so, please clarify.Please indicate any medical or surgical interventions performed.Please describe how was the adhesive was applied on the tape.What prep was used prior to, during or after prineo use? was a dressing placed over the incision? if so, what type of cover dressing used? what is the most current patient status? evaluation: the analysis results found that 11 clr222 devices were returned inside its package unopened.As per evaluation results, it was observed that the returned devices were received unopened and no issues were detected.Device unit was observed to be conforming to product specification.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.No conclusion could be reached as to what may have caused the reported incident.To date additional information requested has not been received.If further details are received at a later date a supplemental medwatch will be sent.
|
|
Event Description
|
It was reported a patient underwent a total knee replacement on (b)(6) 2019 and topical skin adhesive was used.On (b)(6) 2019, post operatively the patient re-presented at day 4 with marked skin reaction at the surgical site.Patient had inflammation, blisters, bruising and wound discharge.Patient was re-admitted to hospital.Treated with antibiotics and wound management.Additional information has been requested.
|
|
Manufacturer Narrative
|
Product complaint #: (b)(4).The following information was requested and the following was obtained: what prep was used prior to, during or after prineo use? betadine (povidone-iodine), or chlorhexidine? chlorhexidine.Was a protective, dry wound dressing such as gauze applied and was it applied only after the liquid topical skin adhesive has completely polymerized and the dermabond¿ prineo¿ is no longer tacky to the touch? no.Was the application site cleansed thoroughly with saline or isopropyl alcohol to remove any remaining blood, fluids, or topical medications/anaesthetics, including skin preps, and then patted dry? yes.Were any patch or sensitivity tests performed prior to the procedure? no.What is the most current patient status? reaction resolved and good cosmetic result.Were any iv steroid/topical steroid/oral steroid/other treatments used to manage the reaction? antibiotics & topical steroid.Who applies the product? the surgeon himself? surgeon only with consistent ifu compliant technique.If the reaction is on the knee, was the product applied while knee was extended or flexed? fully flexed.
|
|
Search Alerts/Recalls
|
|